Skip to content

A Trial to Test an Acceptance-based Therapy Program Among Adolescent Girls With Overweight/Obesity

An Acceptance-based Therapy Intervention vs. an Enhanced Care Condition for Weight Loss Among Adolescent Girls With Overweight/Obesity: A Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04484831
Enrollment
43
Registered
2020-07-24
Start date
2020-07-21
Completion date
2022-07-22
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Weight Loss

Keywords

acceptance-based therapy, adolescents, weight, weight loss, obesity, overweight

Brief summary

The purpose of this study is to investigate the effects of an acceptance-based therapy weight loss intervention compared with enhanced care for adolescents.

Detailed description

Participants will complete baseline assessments and adolescents will be randomized to either an ABT weight loss intervention or enhanced care. The intervention will include 15 sessions over 6 months. Enhanced care will include 15 healthy lifestyle handouts over 6 months. Post-treatment assessments will occur.

Interventions

This includes 15 sessions that are each 90 minutes in length. Intervention sessions will be weekly for the first 2 months, bi-weekly for the next 2 months, and monthly for the last 2 months.

This includes 15 handouts on elements of a healthy lifestyle and a midpoint one-on-one nutrition consultation with a registered dietitian.

Sponsors

StayWell
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
WellCare Health Plans, Inc.
CollaboratorINDUSTRY
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Adolescent between ages 14-19 with overweight or obesity at or above the 85th percentile for sex and age as determined by CDC growth charts

Exclusion criteria

* Known pregnancy or plans to become pregnant in the next 2 years * Plans to move out of the area in the next year * Autism, any intellectual disability (e.g., down syndrome) * Any condition prohibiting physical activity * A diagnosis of cardiovascular disease or diabetes * Have active cancer or cancer requiring treatment in the past 2 years * Have active or chronic infections (e.g., HIV or TB) * Have active kidney disease or lung disease * An eating disorder or substance abuse disorder * Having recently begun a course of or changed the dosage of any medications known to affect appetite or body composition * Weight loss greater than or equal to 5% in the previous 6 months * If they do not follow the study plan

Design outcomes

Primary

MeasureTime frameDescription
BMI Change, 95th BMI Percentile (%)Baseline; Month 6Changes in weight relative to the BMI at the 95th percentile based on sex-and-age (as a difference in percentage units and/or a difference in BMI units) will be evaluated.

Secondary

MeasureTime frameDescription
Change in Quality of LifeBaseline; Month 6Measurements of quality of life (using the valid Pediatric Quality of Life Inventory assessment: scores 0-100) will be conducted. Higher scores indicate better health-related quality of life.
Change in Depression Using the Valid Beck Depression Inventory-IIBaseline; Month 6Depression is measured with the Beck Depression Inventory- II (BDI-II). The BDI-II measures the severity of depression. Each item is assessed on a 4-point ordinal categorical scale (0-3 points) that is specific to the question subject matter being addressed (e.g. sadness, self-criticalness, loss of pleasure, etc), and then answer choices are summed to generate a total score. The BDI-II is reliable and valid in an adolescent population. Participants receive a sum-score (ranging from 0-63), which correlates with a certain classification and level of depression. Scores 1-10 (normal ups and downs) and 11-16 (mild mood disturbance) are classified as low. Scores 17-20 (borderline clinical depression) and 21-30 (moderate depression) are classified as moderate. Scores 31-40 (severe depression) and 40+ (extreme depression) are classified as significant.
Change in Anxiety-sensitivity Using the Valid Short Scale Anxiety Sensitivity Index AssessmentBaseline; Month 6Measurements of anxiety-sensitivity (using the valid Short Scale Anxiety Sensitivity Index-3 assessment: scores 0-20) will be conducted. Higher scores indicate higher anxiety-sensitivity.

Countries

United States

Participant flow

Recruitment details

43 participants completed the informed consent process. 40 continued on to randomization and baseline measurements.

Participants by arm

ArmCount
ABT Weight Loss Intervention
Adolescent participants will attend sessions that include nutritional education and physical activity education and build skills in the areas of values clarification, mindfulness, self-regulation skills, acceptance of uncomfortable states, goal-setting, problem solving, and self-monitoring. ABT Weight Loss Intervention: This includes 15 sessions that are each 90 minutes in length. Intervention sessions will be weekly for the first 2 months, bi-weekly for the next 2 months, and monthly for the last 2 months.
20
Enhanced Care
Adolescent participants will receive handouts on elements of a healthy lifestyle and will participate in a midpoint one-on-one nutrition consultation with a registered dietitian. Enhanced Care: This includes 15 handouts on elements of a healthy lifestyle and a midpoint one-on-one nutrition consultation with a registered dietitian.
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicABT Weight Loss InterventionEnhanced CareTotal
Age, Continuous15.50 Years
STANDARD_DEVIATION 1.54
16.05 Years
STANDARD_DEVIATION 1.54
15.78 Years
STANDARD_DEVIATION 1.54
BMI32.66 kg/m^2
STANDARD_DEVIATION 5.53
34.68 kg/m^2
STANDARD_DEVIATION 7.73
33.67 kg/m^2
STANDARD_DEVIATION 6.71
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants3 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
19 Participants17 Participants36 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Highest Parental Education
Completed Tech or Vocational School/College Graduate
3 Participants5 Participants8 Participants
Highest Parental Education
Graduate or professional degree
10 Participants8 Participants18 Participants
Highest Parental Education
Some college/Associate degree
5 Participants4 Participants9 Participants
Highest Parental Education
Some High School/High School Diploma/GED
2 Participants3 Participants5 Participants
Race
Black
4 Participants2 Participants6 Participants
Race
Other
2 Participants1 Participants3 Participants
Race
White
14 Participants17 Participants31 Participants
Sex: Female, Male
Female
20 Participants20 Participants40 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

BMI Change, 95th BMI Percentile (%)

Changes in weight relative to the BMI at the 95th percentile based on sex-and-age (as a difference in percentage units and/or a difference in BMI units) will be evaluated.

Time frame: Baseline; Month 6

ArmMeasureValue (MEAN)Dispersion
ABT Weight Loss InterventionBMI Change, 95th BMI Percentile (%)-1.11 Change in the 95th BMI percentile %Standard Deviation 5.93
Enhanced CareBMI Change, 95th BMI Percentile (%)-0.08 Change in the 95th BMI percentile %Standard Deviation 8.05
Secondary

Change in Anxiety-sensitivity Using the Valid Short Scale Anxiety Sensitivity Index Assessment

Measurements of anxiety-sensitivity (using the valid Short Scale Anxiety Sensitivity Index-3 assessment: scores 0-20) will be conducted. Higher scores indicate higher anxiety-sensitivity.

Time frame: Baseline; Month 6

ArmMeasureValue (MEAN)Dispersion
ABT Weight Loss InterventionChange in Anxiety-sensitivity Using the Valid Short Scale Anxiety Sensitivity Index Assessment1.00 score on a scaleStandard Deviation 3.65
Enhanced CareChange in Anxiety-sensitivity Using the Valid Short Scale Anxiety Sensitivity Index Assessment1.00 score on a scaleStandard Deviation 5.63
Secondary

Change in Depression Using the Valid Beck Depression Inventory-II

Depression is measured with the Beck Depression Inventory- II (BDI-II). The BDI-II measures the severity of depression. Each item is assessed on a 4-point ordinal categorical scale (0-3 points) that is specific to the question subject matter being addressed (e.g. sadness, self-criticalness, loss of pleasure, etc), and then answer choices are summed to generate a total score. The BDI-II is reliable and valid in an adolescent population. Participants receive a sum-score (ranging from 0-63), which correlates with a certain classification and level of depression. Scores 1-10 (normal ups and downs) and 11-16 (mild mood disturbance) are classified as low. Scores 17-20 (borderline clinical depression) and 21-30 (moderate depression) are classified as moderate. Scores 31-40 (severe depression) and 40+ (extreme depression) are classified as significant.

Time frame: Baseline; Month 6

ArmMeasureValue (MEAN)Dispersion
ABT Weight Loss InterventionChange in Depression Using the Valid Beck Depression Inventory-II-2.81 score on a scaleStandard Deviation 11.58
Enhanced CareChange in Depression Using the Valid Beck Depression Inventory-II0.71 score on a scaleStandard Deviation 12.26
Secondary

Change in Quality of Life

Measurements of quality of life (using the valid Pediatric Quality of Life Inventory assessment: scores 0-100) will be conducted. Higher scores indicate better health-related quality of life.

Time frame: Baseline; Month 6

ArmMeasureValue (MEAN)Dispersion
ABT Weight Loss InterventionChange in Quality of Life2.94 score on a scaleStandard Error 10.86
Enhanced CareChange in Quality of Life3.12 score on a scaleStandard Error 11.15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026